ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,093Medicare Part D Prescriptions Filled, Including Refills

Rank: 295 out of 1185

$356K Total Retail Price of All Prescriptions

Rank: 434 out of 1185

385 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
44% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 385 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

31% of this provider’s 385 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 6,421 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
HYDROCODONE-ACETAMINOPHEN 662 431 S3 1 2
AMLODIPINE BESYLATE 444 395 2 1
LEVOTHYROXINE SODIUM 337 256 3 3
ZOLPIDEM TARTRATE 286 266 4 15
OMEPRAZOLE 270 193 5 6
LISINOPRIL 263 176 6 4
PRAVASTATIN SODIUM 213 192 7 7
ATORVASTATIN CALCIUM 205 145 8 11
CITALOPRAM HBR 155 112 9 22
METFORMIN HCL ER 153 131 10 35
RANITIDINE HCL 151 113 11 17
FUROSEMIDE 143 126 12 8
METOPROLOL SUCCINATE 139 135 13 20
CRESTOR 137 121 14 23
SIMVASTATIN 131 117 15 5
METOPROLOL TARTRATE 116 78 16 10
WARFARIN SODIUM 110 105 17 21
NEXIUM 108 82 18 19
ALENDRONATE SODIUM 98 98 19 40
AZITHROMYCIN 90 70 20 39
DIOVAN HCT 86 65 21 46
LISINOPRIL-HYDROCHLOROTHIAZIDE 83 68 22 14
POTASSIUM CHLORIDE 83 65 22 18
DILTIAZEM ER 78 57 24 153
SERTRALINE HCL 78 60 24 25
GABAPENTIN 75 58 26 13
GLIMEPIRIDE 74 68 27 49
FLUOXETINE HCL 70 48 28 52
TRAZODONE HCL 67 51 29 38
ESCITALOPRAM OXALATE 65 52 30 79
LANTUS 64 43 31 66
TAMSULOSIN HCL 64 64 31 34
PANTOPRAZOLE SODIUM 63 56 33 58
PREMARIN 57 36 R 34 152
ZOSTAVAX 56 48 35 262
TRIAMCINOLONE ACETONIDE 56 42 35 130
DIGOXIN 55 55 37 67
LOSARTAN POTASSIUM 55 55 37 26
FLUTICASONE PROPIONATE 54 43 39 29
FINASTERIDE 53 50 40 132
KLOR-CON M20 50 49 41 59
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 19, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.